Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Cleavage of the leptin receptor by matrix metalloproteinase-2 promotes leptin resistance and obesity in mice.

Mazor R, Friedmann-Morvinski D, Alsaigh T, Kleifeld O, Kistler EB, Rousso-Noori L, Huang C, Li JB, Verma IM, Schmid-Schönbein GW.

Sci Transl Med. 2018 Aug 22;10(455). pii: eaah6324. doi: 10.1126/scitranslmed.aah6324.

PMID:
30135249
2.

Second Language Interference during First Language Processing by Arabic-English Bilinguals.

Alsaigh T, Kennison SM.

Front Psychol. 2017 Nov 7;8:1956. doi: 10.3389/fpsyg.2017.01956. eCollection 2017.

3.

In vivo analysis of intestinal permeability following hemorrhagic shock.

Alsaigh T, Chang M, Richter M, Mazor R, Kistler EB.

World J Crit Care Med. 2015 Nov 4;4(4):287-95. doi: 10.5492/wjccm.v4.i4.287. eCollection 2015 Nov 4.

4.

Cellular and molecular basis of Venous insufficiency.

Pocock ES, Alsaigh T, Mazor R, Schmid-Schönbein GW.

Vasc Cell. 2014 Dec 12;6(1):24. doi: 10.1186/s13221-014-0024-5. eCollection 2014.

5.

Matrix metalloproteinase-1-mediated up-regulation of vascular endothelial growth factor-2 in endothelial cells.

Mazor R, Alsaigh T, Shaked H, Altshuler AE, Pocock ES, Kistler EB, Karin M, Schmid-Schönbein GW.

J Biol Chem. 2013 Jan 4;288(1):598-607. doi: 10.1074/jbc.M112.417451. Epub 2012 Nov 15.

6.

Breakdown of mucin as barrier to digestive enzymes in the ischemic rat small intestine.

Chang M, Alsaigh T, Kistler EB, Schmid-Schönbein GW.

PLoS One. 2012;7(6):e40087. doi: 10.1371/journal.pone.0040087. Epub 2012 Jun 29.

7.

Impaired small-bowel barrier integrity in the presence of lumenal pancreatic digestive enzymes leads to circulatory shock.

Kistler EB, Alsaigh T, Chang M, Schmid-Schönbein GW.

Shock. 2012 Aug;38(3):262-7. doi: 10.1097/SHK.0b013e31825b1717.

8.

Acute venous occlusion enhances matrix metalloprotease activity: Implications on endothelial dysfunction.

Alsaigh T, Pocock ES, Bergan JJ, Schmid-Schönbein GW.

Microvasc Res. 2011 Jan;81(1):108-16. doi: 10.1016/j.mvr.2010.09.010. Epub 2010 Oct 16.

9.

Mechanisms in experimental venous valve failure and their modification by Daflon 500 mg.

Pascarella L, Lulic D, Penn AH, Alsaigh T, Lee J, Shin H, Kapur V, Bergan JJ, Schmid-Schönbein GW.

Eur J Vasc Endovasc Surg. 2008 Jan;35(1):102-10. Epub 2007 Sep 24.

Supplemental Content

Loading ...
Support Center